CSIMarket
 

Novan Inc   (NASDAQ: NOVN)

Novan Inc 's

Competitiveness




 

NOVN Sales vs. its Competitors Q1 2023



Comparing the current results to its competitors, Novan Inc reported Revenue increase in the 1 quarter 2023 by 64.21 % year on year, while most of its competitors have experienced contraction in revenues by -12.22 %, achieved in the same quarter.

List of NOVN Competitors





Revenue Growth Comparisons




Net Income Comparison


Novan Inc , slower than the average decrease reported by the company's competitors of -30.46 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -30.46 %

<<  NOVN Stock Performance Comparisons



  

Overall company Market Share Q1 2023

Due to outstanding performance in Overall company, revenue grew by 64.21 % Novan Inc improved its market share, to approximately 0 %.




<<  More on NOVN Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Novan Inc




Verastem Inc
Share Performance



+38.04%
30 Days



Verastem Inc
Profile

Verastem Inc is a biopharmaceutical company that focuses on discovering and developing medicines to treat cancer by targeting the underlying biology of the disease. They employ a research-driven business model to identify novel therapeutic candidates, evaluate their potential through preclinical and clinical trials, and bring them to market with the goal of improving patient outcomes. Verastem emphasizes innovation, precision medicine, and strategic collaborations to advance their pipeline of cancer therapeutics.

More about Verastem Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 795.167 mill. $ 49.585 mill. $ -193.959 mill.


Clene Inc
Share Performance



-10.54%
Over The Past 5 Days



Clene Inc
Profile

Clene Inc's business model focuses on developing and commercializing novel nanocatalysts to enhance energy storage systems and improve the efficiency and performance of clean energy technologies.

More about Clene Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 51.512 mill. $ 0.197 mill. $ -39.518 mill.


Cellectar Biosciences Inc
Share Performance



-29.97%
This Year



Cellectar Biosciences Inc
Profile

Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.

More about Cellectar Biosciences Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 10.304 mill. $ - mill. $ -20.841 mill.


Journey Medical Corp
Share Performance



+27.59%
This Quarter



Journey Medical Corp
Profile

Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.

More about Journey Medical Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 212.160 mill. $ 64.680 mill. $ -9.588 mill.


Eqrx Inc
Share Performance



+4.93%
30 Days



Eqrx Inc
Profile

Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.

More about Eqrx Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,133.098 mill. $ - mill. $ -259.623 mill.

72 more competitors available

Sign in to see all competitors

Sources: Novan Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Novan Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.